Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior

[1]  R. D. L. Garza.  Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia , 2005, Neuroscience & Biobehavioral Reviews.

[2]  A. Dunn,et al.  Cytokines as mediators of depression: What can we learn from animal studies? , 2005, Neuroscience & Biobehavioral Reviews.

[3]  J. Cryan,et al.  The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice , 2005, Neuroscience & Biobehavioral Reviews.

[4]  J. Weiss,et al.  The subdiaphragmatic vagus nerves mediate activation of locus coeruleus neurons by peripherally administered microbial substances , 2005, Neuroscience.

[5]  A. Świergiel,et al.  Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice , 2005, Pharmacology Biochemistry and Behavior.

[6]  Kelly A. Bordner,et al.  Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide , 2005, Behavioural Brain Research.

[7]  C. Le Moine,et al.  A Specific Limbic Circuit Underlies Opiate Withdrawal Memories , 2005, The Journal of Neuroscience.

[8]  C. Barnes,et al.  Neuroinflammation Alters the Hippocampal Pattern of Behaviorally Induced Arc Expression , 2005, The Journal of Neuroscience.

[9]  C. McClung,et al.  DeltaFosB: a molecular switch for long-term adaptation in the brain. , 2004, Brain research. Molecular brain research.

[10]  M. Barrot,et al.  Induction of ΔFosB in Reward-Related Brain Structures after Chronic Stress , 2004, The Journal of Neuroscience.

[11]  Robert Dantzer,et al.  Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. , 2004, European journal of pharmacology.

[12]  G. Wenk,et al.  Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors , 2004, Journal of Neuroinflammation.

[13]  S. Matthews,et al.  Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C. , 2004, Psychosomatics.

[14]  R. Dantzer,et al.  Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats , 2004, Psychoneuroendocrinology.

[15]  J. Weiss,et al.  The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances , 2004, Brain Research.

[16]  B. Šakić,et al.  Behavioral effects of infection with interferon-gamma adenovector , 2004, Behavioural Brain Research.

[17]  R. Dantzer,et al.  Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice , 2004, Brain, Behavior, and Immunity.

[18]  G. Alheid.  Extended Amygdala and Basal Forebrain , 2003, Annals of the New York Academy of Sciences.

[19]  R. Dantzer,et al.  Cytokines and depression: The need for a new paradigm , 2003, Brain, Behavior, and Immunity.

[20]  H. Anisman,et al.  Dissociating anorexia and anhedonia elicited by interleukin-1β: antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake , 2003, Psychopharmacology.

[21]  H. Anisman,et al.  Cytokines, stress and depressive illness: brain‐immune interactions , 2003, Annals of medicine.

[22]  R. Dantzer,et al.  The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen , 2002, Brain, Behavior, and Immunity.

[23]  H. Anisman,et al.  Cytokines, stress, and depressive illness , 2002, Brain, Behavior, and Immunity.

[24]  H. Anisman,et al.  Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes , 2002, Brain, Behavior, and Immunity.

[25]  J. Weiss,et al.  Alteration of Locus coeruleus Neuronal Activity by Interleukin-1 and the Involvement of Endogenous Corticotropin-Releasing Hormone , 2002, Neuroimmunomodulation.

[26]  N. Castanon,et al.  Effects of antidepressants on cytokine production and actions , 2002, Brain, Behavior, and Immunity.

[27]  C. Nemeroff,et al.  Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions , 2002, Neuropsychopharmacology.

[28]  B. Everitt,et al.  Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.

[29]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[30]  G. Goodall,et al.  Antidepressant reversal of interferon-α-induced anhedonia , 2002, Physiology & Behavior.

[31]  R. Dantzer,et al.  Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.

[32]  R. Dantzer,et al.  Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy , 2001, Psychoneuroendocrinology.

[33]  S. Kulkarni,et al.  Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. , 2001, Methods and findings in experimental and clinical pharmacology.

[34]  M. Barrot,et al.  ΔFosB: A sustained molecular switch for addiction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[36]  B. Leonard.  The immune system, depression and the action of antidepressants , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  Y. Nakabeppu,et al.  Enhancement of Laminar FosB Expression in Frontal Cortex of Rats Receiving Long Chronic Clozapine Administration , 2001, Experimental Neurology.

[38]  R. Dantzer.  Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[39]  M Liotti,et al.  The Role of Functional Neuroimaging in the Neuropsychology of Depression , 2001, Journal of clinical and experimental neuropsychology.

[40]  S. Maier,et al.  Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats , 2000, Autonomic Neuroscience.

[41]  S. Maier,et al.  Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever , 2000, Autonomic Neuroscience.

[42]  R. Dantzer,et al.  The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis , 2000, The European journal of neuroscience.

[43]  R. Yirmiya.  Depression in medical illness: the role of the immune system. , 2000, The Western journal of medicine.

[44]  R. Dantzer,et al.  Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  R. Hirschfeld.  History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.

[46]  R. Yirmiya,et al.  The Immunobiology of Sexual Behavior Gender Differences in the Suppression of Sexual Activity During Illness , 1999, Pharmacology Biochemistry and Behavior.

[47]  J. Kelly,et al.  Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. , 1999, Life sciences.

[48]  N. Hiroi,et al.  Region‐specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs , 1999, Synapse.

[49]  M. Kelz,et al.  ΔFosB: a molecular mediator of long-term neural and behavioral plasticity 1 Published on the World Wide Web on 27 November 1998. 1 , 1999, Brain Research.

[50]  Yvette I. Sheline,et al.  Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.

[51]  R. Dantzer,et al.  Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 β and inducible nitric oxide synthase in rat brain , 1999, Neuroscience.

[52]  H. Anisman,et al.  Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia , 1998, Neuroreport.

[53]  T. Herdegen,et al.  Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins , 1998, Brain Research Reviews.

[54]  K. Kovács,et al.  Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map , 1998, Neurochemistry International.

[55]  M. Kelz,et al.  Chronic Fos-Related Antigens: Stable Variants of ΔFosB Induced in Brain by Chronic Treatments , 1997, The Journal of Neuroscience.

[56]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[57]  L. Heimer,et al.  Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders , 1997, Neuroscience.

[58]  C. D. Jacobson,et al.  Distribution of fos‐like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration , 1996, The Journal of comparative neurology.

[59]  S. Checkley,et al.  The neuroendocrinology of depression and chronic stress. , 1996, British medical bulletin.

[60]  R. Yirmiya.  Endotoxin produces a depressive-like episode in rats , 1996, Brain Research.

[61]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[62]  P. Willner,et al.  Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine , 1995, Psychopharmacology.

[63]  T. Curran,et al.  Immediate-early genes: ten years on , 1995, Trends in Neurosciences.

[64]  R. Dantzer,et al.  Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.

[65]  E. Brown,et al.  A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  P. Sawchenko,et al.  Mediation of osmoregulatory influences on neuroendocrine corticotropin-releasing factor expression by the ventral lamina terminalis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  T. Noguchi,et al.  Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. , 1991, Molecular and cellular biology.

[68]  J. Borrell,et al.  Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF , 1990, Brain Research.

[69]  L. Heimer,et al.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata , 1988, Neuroscience.

[70]  R. De La Garza.  Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. , 2005, Neuroscience and biobehavioral reviews.

[71]  M. Danik,et al.  Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL‐β‐dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons , 2005, Hippocampus.

[72]  M. Maes,et al.  IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity , 2005, Molecular Psychiatry.

[73]  C. Moine,et al.  The Motivational Component of Withdrawal in Opiate Addiction: Role of Associative Learning and Aversive Memory in Opiate Addiction from a Behavioral, Anatomical and Functional Perspective , 2005, Reviews in the neurosciences.

[74]  M. Barrot,et al.  Induction of deltaFosB in reward-related brain structures after chronic stress. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  M. Wichers,et al.  The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. , 2004, Journal of psychiatry & neuroscience : JPN.

[76]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[77]  R. Dantzer,et al.  Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy , 2002, Molecular Psychiatry.

[78]  G. Goodall,et al.  Antidepressant reversal of interferon-alpha-induced anhedonia. , 2002, Physiology & behavior.

[79]  M. Barrot,et al.  DeltaFosB: a sustained molecular switch for addiction. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[80]  T. Stone,et al.  Endogenous neurotoxins from tryptophan. , 2001, Toxicon : official journal of the International Society on Toxinology.

[81]  R. Porsolt.  Animal Models of Depression: Utility for Transgenic Research , 2000, Reviews in the neurosciences.

[82]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[83]  M. Makino,et al.  Human interferon-α increases immobility in the forced swimming test in rats , 2000, Psychopharmacology.

[84]  K. Miyata,et al.  Corticotropin-Releasing Hormone1 Receptors Mediate Consensus Interferon-α YM643-Induced Depression-Like Behavior in Mice , 2000 .

[85]  M. Makino,et al.  Human interferon-alpha increases immobility in the forced swimming test in rats. , 2000, Psychopharmacology.

[86]  K. Miyata,et al.  Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice. , 2000, The Journal of pharmacology and experimental therapeutics.

[87]  R. Dantzer,et al.  Cytokines and depression: fortuitous or causative association? , 1999, Molecular Psychiatry.

[88]  A. Dunn,et al.  Effects of Cytokines on Cerebral Neurotransmission , 1999 .

[89]  A. Dunn,et al.  Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. , 1999, Advances in experimental medicine and biology.

[90]  R E Harlan,et al.  The accumbens: beyond the core-shell dichotomy. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[91]  L. Heimer,et al.  Theories of basal forebrain organization and the "emotional motor system". , 1996, Progress in brain research.

[92]  G. Soma,et al.  Effects of a lipopolysaccharide from Pantoea agglomerans on the cocaine-induced place preference. , 1994, Life sciences.

[93]  G. Holstege,et al.  The emotional motor system. , 1992, European journal of morphology.